DREAM Intervention for Type 1 Diabetes

(DREAM Trial)

This trial aims to help Latinx teens with type 1 diabetes (T1D) use technology like insulin pumps and continuous glucose monitors more effectively. The researchers seek to determine if a virtual peer group (VPG) intervention, called the DREAM intervention (Device Use Reimagined Through Education And Mentorship), can improve glucose control and make using these devices more acceptable and feasible. Teens with T1D who receive care at certain California medical centers and identify as Latinx are ideal candidates. Participants will join virtual groups to discuss various topics, with sessions available in both English and Spanish. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance diabetes management for Latinx teens.

The trial information does not specify whether you need to stop taking your current medications.

Research has shown that the DREAM program is designed to help Latinx teenagers with type 1 diabetes improve their use of diabetes technology, such as insulin pumps and continuous glucose monitors. The program promotes the use of these devices through online peer groups, where participants receive support and motivation from others in similar situations.

Currently, no specific information exists on side effects or problems associated with the DREAM program. However, as a support program rather than a new drug or device, any risks are expected to be low. The program aims to enhance the use of these devices, which is generally safe and beneficial for managing type 1 diabetes.

Researchers are excited about the DREAM intervention for Type 1 Diabetes because it offers a fresh, community-focused approach. Unlike traditional treatments that primarily focus on insulin management, this intervention emphasizes support through virtual peer groups (VPGs) and optional in-person events. By fostering community and education among youth and caregivers in both English and Spanish, it aims to improve diabetes management through shared experiences and support. This approach could address the emotional and social challenges of living with Type 1 Diabetes, which are often overlooked by standard medical treatments.

Research has shown that the DREAM program, which participants in this trial may receive, aims to help Latinx teenagers with type 1 diabetes (T1D) improve their use of diabetes devices. Studies suggest that combining technology with education and mentorship can simplify diabetes management. The program seeks to increase the use of continuous glucose monitors, which track blood sugar levels, and other diabetes tools. Early results indicate that this approach can lead to better blood sugar control and overall health for participants. By offering support through online peer groups, the program may help fill gaps in diabetes care for these young people.¹²³⁴⁶